A securities fraud class action lawsuit has been filed against GeneDx Holdings Corp. on behalf of investors who purchased or acquired WGS common stock between April 16, 2025, and May 4, 2026. The lawsuit, filed in the United States District Court for the District of Connecticut, alleges that the company made materially false and misleading statements regarding the viability of its acquisition of Fabric Genomics. On May 4, 2026, GeneDx announced first quarter results that included a $31.3 million impairment loss directly attributable to Fabric, which was only $5.2 million less than the acquisition price, causing the share price to fall more than 49%. Investors have until August 3, 2026, to seek lead plaintiff status through Kessler Topaz Meltzer & Check, LLP or other counsel.
GeneDx Holdings Corp.Securities fraud class action lawsuit alleges false statements about Fabric Genomics acquisition; stock fell 49% after impairment loss
ServiceNow Inc